• All News
• 2023
• 2022
• 2021
• 2020
• 2019
• 2017
• 2016
• 2015
• 2014

Xenetic Biosciences to Present at the 29th Annual ROTH Conference

Mar 9, 2017

Xenetic Biosciences Receives $3 Million Milestone Payment from Shire plc for PSA-Recombinant SHP656 in Development for Long-Acting Treatment for Hemophilia

Jan 6, 2017

Xenetic Biosciences Appoints Curtis A. Lockshin, Ph.D. as Chief Scientific Officer

Jan 4, 2017

Xenetic Biosciences to Present at Biotech Showcase 2017

Jan 3, 2017

Xenetic Biosciences Expands Management Team with Key Appointment of Jeffrey F. Eisenberg as Chief Operating Officer

Dec 5, 2016

Xenetic Biosciences to Present at the LD Micro 2016 Annual Conference

Dec 1, 2016

Xenetic Biosciences to Host Quarterly Update Conference Call and Webcast

Nov 23, 2016

Xenetic Biosciences Appoints Edward J. Benz, Jr., M.D., Former Dana-Farber CEO, to its Board of Directors

Nov 22, 2016

Xenetic Biosciences Reports Third Quarter Financial Results and Provides Business Update

Nov 15, 2016

Xenetic Biosciences Announces the Closing of its $10M Public Offering

Nov 7, 2016

• « Previous
• 1...
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• Next »